Imagine a tiny, invisible fortress, a slimy shield built by bacteria that makes them practically invincible against our best medicines. This isn’t a scene from a sci-fi movie; it’s the grim reality of “superbugs” like Klebsiella pneumoniae, a pathogen that thrives in hospitals and poses a critical global threat, especially in stubbornly infected wounds. For … Read more
Could a medication you or a loved one takes for Parkinson’s disease be quietly altering the delicate ecosystem inside your gut? A recent study published in Nature Microbiology reveals a surprising discovery: entacapone, a common drug used to treat Parkinson’s, appears to significantly disrupt the human gut microbiome by essentially cutting off its iron supply. … Read more
In a startling development that could redefine cancer treatment, scientists have successfully engineered a common probiotic yeast to act as a miniature drug delivery system, shrinking hard-to-reach intestinal tumors in mice. This groundbreaking work, out of Washington University School of Medicine in St. Louis, offers a glimmer of hope for a less invasive, oral treatment … Read more
The nightmare scenario of antibiotic resistance, where common infections become untreatable, looms large. But what if the answer to fighting superbugs isn’t more powerful drugs, but rather a tiny army of good bacteria already living inside us? Groundbreaking research from INRAE scientists suggests exactly that. They’ve identified a “consortium of seven commensal bacteria”—a fancy term … Read more
A groundbreaking discovery from the University of Cincinnati suggests a future where fighting off viruses like the flu, COVID-19, or even new pandemics might no longer require an injection. Instead, it could be as simple as taking a pill. New research reveals how specially designed bacteria, swallowed like any other medication, can act as a … Read more
Scientists have created a revolutionary “smart pill,” a battery-free ingestible biosensor that offers new opportunities to understand human gut health.
Researchers have made a groundbreaking discovery that could explain why nonsteroidal anti-inflammatory drugs (NSAIDs) can worsen gastrointestinal infections caused by Clostridioides difficile, commonly known as C. diff.
Scientists have demonstrated for the first time that treatments with engineered bacteria can significantly improve the quality of life in patients with C. difficile infections
Fecal transplants could be the answer to treating one of the most common life-threatening intestinal infections.
Researchers at Washington University School of Medicine in St. Louis have revealed two key transition points in the development of pancreatic cancer.